Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987714 · ClinicalTrials.gov registry record · NA
Monitoring Organ Donors to Increase Transplantation Results (MOnIToR)
A NA study of Transplantation, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 556
- Enrollment target
- 8
- Study locations
NCT00987714: Completed NA study of Transplantation, sponsored by University of Pittsburgh.
NCT00987714 is a NA study of Transplantation that has completed, run by University of Pittsburgh. The registered enrollment target is 556 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00987714, a NA study of Transplantation, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 556 participants
- Enrollment target
- 8
- Study locations
Study Summary
The objective of this study is to determine whether protocol guided resuscitation of brain dead organ donors using Pulse Pressure Variation (PPV) will increase the number of organs transplanted per donor. Specifically the study aims to: 1. improve resuscitation of potential organ donors. 2. improve organ function in donors. 3. increase organ recovery per donor. The investigators will randomize 960 subjects to either protocolized resuscitation (n=480) using a consensus-based PPV-guided algorithm or usual care using a 1:1 randomization scheme. The primary outcome is the mean number of organs transplanted per donor. Secondary outcomes include 6mHFS (six-month hospital-free survival) in the recipients, and mean number of organs procured per donor that are suitable for transplantation (intention to transplant). The study is powered to detect a 0.5 organ increase for transplantation per donor.
Conditions Studied
Interventions
- PROCEDURE Protocolized care
Study Locations (8)
Ohio
- LifeBanc - Cleveland
- Lifeline of Ohio - Columbus
Georgia
- LifeLink of Georgia - Norcross
Oklahoma
- LifeShare of Oklahoma - Oklahoma City
Pennsylvania
- Center for Organ Recovey and Education - Pittsburgh
Tennessee
- Tennessee Donor Services - Knoxville
Texas
- Southwest Transplant Alliance-Dallas - Dallas
Washington
- Lifecenter North West - Bellevue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 556 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-03 |
| Phase | NA |
What the finished NCT00987714 record still lists
NCT00987714 is an interventional study that assigns participants to a tested intervention. The registered 556 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Protocolized care is the first listed.
NCT00987714 lists 8 locations in 7 states (Ohio, Georgia, Oklahoma).
Frequently Asked Questions
What is clinical trial NCT00987714 about?
NCT00987714 is a clinical study titled "Monitoring Organ Donors to Increase Transplantation Results (MOnIToR)". The objective of this study is to determine whether protocol guided resuscitation of brain dead organ donors using Pulse Pressure Variation (PPV) will increase the number of organs transplanted per donor. Specifically the study aims to: 1. improve resuscitation of potential organ donors. 2. improv...
What is the current status of trial NCT00987714?
This trial is currently completed. It is a NA study. The enrollment target is 556 participants. The study started on 2009-08. Estimated completion is 2013-03.
What conditions does trial NCT00987714 study?
This clinical trial studies the following conditions: Transplantation.
What interventions are being tested in trial NCT00987714?
The interventions under investigation include: Protocolized care (PROCEDURE).
Who is sponsoring clinical trial NCT00987714?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00987714 being conducted?
This trial has 8 study locations across Georgia, Ohio, Oklahoma, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00987714's enrollment target sits among peer trials
556 184th of 2000 higher than 1,817 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06074588 · 556 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
- NCT06693622 · 556 participants
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
- NCT05708885 · 557 participants · NA
Striated Esophageal Motor Function Modulation in Health and Disease
- NCT06799000 · 555 participants · Phase 3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia